New Guidelines for Diagnosis of Gestational Diabetes

Pathology-Based Impact Assessment

Ezekiel (Uba) Nwose, Ross Richards, P Bwititi, E Butkowski

    Research output: Contribution to journalArticleResearchpeer-review

    1 Downloads (Pure)

    Abstract

    Background: A recent study indicated an average of 19.5% abnormal oral glucose tolerance in antenatal clients per year. Aim: The purpose of this study was to determine the impact on gestational diabetes cases due to new guidelines for diagnosis and classification of hyperglycaemia in pregnancy. Materials and Methods: This study reviewed the archived clinical pathology data on oral glucose tolerance tests performed between January 1999 and December 2008 on antenatal clients (N = 615). The cases were reviewed to determine changes if any in percentage of gestational diabetes due to new guidelines. Results: Over the 10 years period, a yearly average of additional 10.8% antenatal cases suggestive of gestational diabetes was observed due to the new recommended thresholds. Further, the average yearly incidence would have increased from 8.8 cases to 16.2 cases, which translates to almost 46% increase in the prospective numbers of gestational diabetes. Conclusions: This report presents the extent of how the new recommended guidelines for diagnosis and classification of hyperglycaemia in pregnancy could increase the prevalence of gestational diabetes. It also provides pathology-based evidence for the epidemiology of gestational diabetes mellitus and allows for planning the costs that would be attendant to the full implementation of the new guidelines.
    Original languageEnglish
    Pages (from-to)191-194
    Number of pages4
    JournalNorth American Journal of Medical Sciences
    Volume5
    Issue number3
    DOIs
    Publication statusPublished - 2013

    Fingerprint

    Gestational Diabetes
    Guidelines
    Pathology
    Glucose Tolerance Test
    Hyperglycemia
    Pregnancy
    Clinical Pathology
    Epidemiology
    Costs and Cost Analysis
    Incidence

    Cite this

    Nwose, Ezekiel (Uba) ; Richards, Ross ; Bwititi, P ; Butkowski, E. / New Guidelines for Diagnosis of Gestational Diabetes : Pathology-Based Impact Assessment. In: North American Journal of Medical Sciences. 2013 ; Vol. 5, No. 3. pp. 191-194.
    @article{62fffaee7d55468590a037550c56f871,
    title = "New Guidelines for Diagnosis of Gestational Diabetes: Pathology-Based Impact Assessment",
    abstract = "Background: A recent study indicated an average of 19.5{\%} abnormal oral glucose tolerance in antenatal clients per year. Aim: The purpose of this study was to determine the impact on gestational diabetes cases due to new guidelines for diagnosis and classification of hyperglycaemia in pregnancy. Materials and Methods: This study reviewed the archived clinical pathology data on oral glucose tolerance tests performed between January 1999 and December 2008 on antenatal clients (N = 615). The cases were reviewed to determine changes if any in percentage of gestational diabetes due to new guidelines. Results: Over the 10 years period, a yearly average of additional 10.8{\%} antenatal cases suggestive of gestational diabetes was observed due to the new recommended thresholds. Further, the average yearly incidence would have increased from 8.8 cases to 16.2 cases, which translates to almost 46{\%} increase in the prospective numbers of gestational diabetes. Conclusions: This report presents the extent of how the new recommended guidelines for diagnosis and classification of hyperglycaemia in pregnancy could increase the prevalence of gestational diabetes. It also provides pathology-based evidence for the epidemiology of gestational diabetes mellitus and allows for planning the costs that would be attendant to the full implementation of the new guidelines.",
    keywords = "glucose, article, disease classification, evidence based practice, human, hyperglycemia, incidence, major clinical study, oral glucose tolerance test, pathology, practice guideline, pregnancy diabetes mellitus, prevalence",
    author = "Nwose, {Ezekiel (Uba)} and Ross Richards and P Bwititi and E Butkowski",
    year = "2013",
    doi = "10.4103/1947-2714.109184",
    language = "English",
    volume = "5",
    pages = "191--194",
    journal = "North American Journal of Medical Sciences",
    issn = "2250-1541",
    publisher = "Medknow Publications",
    number = "3",

    }

    New Guidelines for Diagnosis of Gestational Diabetes : Pathology-Based Impact Assessment. / Nwose, Ezekiel (Uba); Richards, Ross; Bwititi, P; Butkowski, E.

    In: North American Journal of Medical Sciences, Vol. 5, No. 3, 2013, p. 191-194.

    Research output: Contribution to journalArticleResearchpeer-review

    TY - JOUR

    T1 - New Guidelines for Diagnosis of Gestational Diabetes

    T2 - Pathology-Based Impact Assessment

    AU - Nwose, Ezekiel (Uba)

    AU - Richards, Ross

    AU - Bwititi, P

    AU - Butkowski, E

    PY - 2013

    Y1 - 2013

    N2 - Background: A recent study indicated an average of 19.5% abnormal oral glucose tolerance in antenatal clients per year. Aim: The purpose of this study was to determine the impact on gestational diabetes cases due to new guidelines for diagnosis and classification of hyperglycaemia in pregnancy. Materials and Methods: This study reviewed the archived clinical pathology data on oral glucose tolerance tests performed between January 1999 and December 2008 on antenatal clients (N = 615). The cases were reviewed to determine changes if any in percentage of gestational diabetes due to new guidelines. Results: Over the 10 years period, a yearly average of additional 10.8% antenatal cases suggestive of gestational diabetes was observed due to the new recommended thresholds. Further, the average yearly incidence would have increased from 8.8 cases to 16.2 cases, which translates to almost 46% increase in the prospective numbers of gestational diabetes. Conclusions: This report presents the extent of how the new recommended guidelines for diagnosis and classification of hyperglycaemia in pregnancy could increase the prevalence of gestational diabetes. It also provides pathology-based evidence for the epidemiology of gestational diabetes mellitus and allows for planning the costs that would be attendant to the full implementation of the new guidelines.

    AB - Background: A recent study indicated an average of 19.5% abnormal oral glucose tolerance in antenatal clients per year. Aim: The purpose of this study was to determine the impact on gestational diabetes cases due to new guidelines for diagnosis and classification of hyperglycaemia in pregnancy. Materials and Methods: This study reviewed the archived clinical pathology data on oral glucose tolerance tests performed between January 1999 and December 2008 on antenatal clients (N = 615). The cases were reviewed to determine changes if any in percentage of gestational diabetes due to new guidelines. Results: Over the 10 years period, a yearly average of additional 10.8% antenatal cases suggestive of gestational diabetes was observed due to the new recommended thresholds. Further, the average yearly incidence would have increased from 8.8 cases to 16.2 cases, which translates to almost 46% increase in the prospective numbers of gestational diabetes. Conclusions: This report presents the extent of how the new recommended guidelines for diagnosis and classification of hyperglycaemia in pregnancy could increase the prevalence of gestational diabetes. It also provides pathology-based evidence for the epidemiology of gestational diabetes mellitus and allows for planning the costs that would be attendant to the full implementation of the new guidelines.

    KW - glucose

    KW - article

    KW - disease classification

    KW - evidence based practice

    KW - human

    KW - hyperglycemia

    KW - incidence

    KW - major clinical study

    KW - oral glucose tolerance test

    KW - pathology

    KW - practice guideline

    KW - pregnancy diabetes mellitus

    KW - prevalence

    U2 - 10.4103/1947-2714.109184

    DO - 10.4103/1947-2714.109184

    M3 - Article

    VL - 5

    SP - 191

    EP - 194

    JO - North American Journal of Medical Sciences

    JF - North American Journal of Medical Sciences

    SN - 2250-1541

    IS - 3

    ER -